1. ACI to report Q4 earnings on April 15. 2. Telsey Advisory predicts in-line results and healthy comps for 2025. 3. Analyst Joseph Feldman maintains Outperform rating with $26 price target. 4. Expected same-store sales growth of 1.7% amid solid grocery demand. 5. 2025 earnings estimate cut from $2.48 to $2.40 per share.
Despite a slight earnings estimate cut, the overall positive outlook and expected growth in same-store sales suggest resilience. Historical examples, like steady growth observed during economic downturns, support a bullish outlook.
The article provides critical insights into ACI's financial expectations and market positioning, highlighting both risks and opportunities, particularly ahead of quarterly earnings.
Long-term growth is anticipated due to digital and pharmacy strength, which influences extended financial stability despite short-term challenges.